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Abstract
Background Dutch patients with an implantable cardioverter defibrillator (ICD) are restricted from driving for two months
after implantation or shocks. This requires significant lifestyle adjustments and is one of the primary concerns of ICD
patients. Previous studies indicated that compliance with the driving restrictions is poor, but insight in socio-demographic,
clinical and psychological factors associated with compliance is limited. Hence, this study aimed to explore compliance
with the driving restrictions and associated factors in a large sample of Dutch ICD patients.
Method Dutch ICD patients (N = 313) completed an elaborative set of questionnaires at time of implantation and at four
months after implantation, assessing socio-demographic, psychological and driving-related characteristics. Clinical data
were collected from the patients’ medical records.
Results A substantial subgroup (28%) of the patient sample (median age 64 (interquartile range = 55–71), 81% male)
reported to have been noncompliant with the driving restrictions. Univariate analysis indicated that noncompliant patients
more often considered refusing the ICD due to the restrictions, compared to compliant patients (19% versus 10%, p = 0.02).
Multivariate analysis showed that the feeling of understanding the reason behind the driving restrictions was associated
with better compliance (odds ratio = 2.16, 95% confidence interval 1.02–4.56, p = 0.04). No other socio-demographic,
clinical, psychological or driving-related factors were associated with compliance.
Conclusion A large number of ICD patients does not comply with the driving restrictions after implantation. This study
emphasised the importance of the patient’s feeling of understanding the reason behind the restrictions.
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Introduction
Implantable cardiac defibrillator (ICD) therapy is the first-
line treatment in the prevention of sudden cardiac death
caused by life-threatening ventricular arrhythmias [1]. De-
spite its medical benefits the ICD imposes some restrictions
on patients that may influence their daily lives. For exam-
ple, patients with an ICD are restricted from driving a motor
vehicle for a set period after the implantation and after ICD
shocks, as they have an ongoing risk of sudden incapaci-
tation that might harm others and themselves when driving
[2]. Importantly, this risk is mainly a consequence of the
underlying disease and not of the presence of an ICD [2].
The driving restrictions require significant lifestyle ad-
justments and are typically one of the primary concerns of
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ICD patients and their families [3]. In quantitative studies,
patients have reported decreased self-esteem, relationship
problems, a sense of loss of independence and social isola-
tion due to the driving restrictions [4, 5]. This might explain
why compliance with these restrictions is poor among ICD
patients [6–9].
Compliance with driving restrictions and its associated
factors have hardly been studied in European samples, and
previous research in this field was conducted more than
a decade ago [6–9]. Better insight into the factors related
to driving after ICD implantation might improve individu-
alised and structured information provision and support for
patients, which could eventually lead to better compliance.
Hence, the aim of this large quantitative study is to exam-
ine: 1) compliance rates; and 2) socio-demographic, clinical
and psychological factors associated with compliance with
driving restrictions in Dutch patients with an ICD.
Method
Dutch driving restrictions after ICD implantation
Dutch driving restrictions were first published in 2000 [10].
Patients with a driving license for motor vehicles >3,500 kg
are permanently prohibited from driving, as well as patients
who transport passengers in a professional setting. Patients
with a driving license for motor vehicles <3,500 kg are re-
stricted from driving for two months after implantation.
Also, passenger transport (in volunteer settings) is limited
to a maximum of nine passengers and only on special re-
quest; professional driving is allowed for <4 h/day. Patients
receive a suitability statement from their cardiologist if their
ICD did not deliver a shock and if no severe haemodynamic
problems occurred during anti-tachycardia pacing in the
first two months after implantation. In addition, no severe
heart failure symptoms are allowed. With this statement, pa-
tients can obtain a special driving license (i. e., ‘code 100’
for private driving and ‘code 101’ for professional driving)
from the Dutch driving licensing centre (Centraal Bureau
Rijvaardigheidsbewijzen—CBR). This procedure takes an-
other few weeks. Code 100 and code 101 licenses are valid
for five years, instead of the standard ten for a regular driv-
ing license. If the ICD delivers one or more appropriate or
inappropriate shocks, the actual restriction of these driving
licenses implies that a patient is unfit to drive for at least
two months after the last shock.
Study design and participants
In this prospective multicentre cohort study in three Dutch
Hospitals (University Medical Center Utrecht, Canisius
Wilhelmina Hospital Nijmegen and Academic Medical
Center Amsterdam), consecutive patients receiving a first-
time ICD with or without cardioverter resynchronisation
therapy (CRT) were included between December 2012 and
March 2015. Patients with a valid driving license were el-
igible for participation. We excluded patients on a waiting
list for heart transplantation, patients with cognitive im-
pairment, patients with insufficient knowledge of the Dutch
language to complete questionnaires and patients with
a life expectancy of <1 year. Approval of local institutional
review boards was obtained and the study was conducted
in accordance with the Declaration of Helsinki (Brazil,
October 2013). All patients provided written informed con-
sent. Patients received a baseline questionnaire one day
after implantation, and were asked to return it within two
weeks. Four months after implantation all patients received
a follow-up questionnaire.
Measures
Socio-demographic and clinical variables
Information on socio-demographic variables was obtained
from purpose-designed questions in the baseline question-
naire. Clinical information was collected from the patients’
medical records.
Compliancewith driving restrictions
Compliance was measured by the following purpose-de-
signed questions in the follow-up questionnaire: ‘Have you
driven a motor vehicle before receiving a code 100 driving
license?’ and ‘How many weeks after implantation did you
resume driving a motor vehicle?’ If a patient answered the
first question with a ‘yes’ and/or the second question with
‘< eight weeks’, he was classified as noncompliant.
Driving behaviour before ICD implantation
Patients’ driving behaviour before ICD implantation was
assessed using purpose-designed questions in the baseline
questionnaires. Patients were asked which driving license(s)
they have, if their partner has a driving license, if they are
the main driver in their family, how many days per week
they drive a motor vehicle, how many kilometres per week
they drive, if driving is mostly for work or private purposes,
and if they mostly drive within or outside urbanised areas.
Information provision regarding the driving
restrictions
Information provision about the driving restrictions was
measured with purpose-designed questions in the follow-
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up questionnaire. Patients were asked whether they received
information about the restrictions, in what way, from whom
and at which moment. They were asked if the information
provision was sufficient, if the reason behind the driving
restriction was clear to them, whether they felt the driv-
ing restrictions were acceptable, and if they had considered
refusing ICD implantation because of the restrictions.
Psychological variables
The distressed (Type D) personality, a combined tendency
towards negative affectivity and social inhibition, was as-
sessed with the 14-item Type D Scale (DS14). The items on
this scale are rated on a 5-point Likert scale ranging from 0
(false) to 4 (true) and can be divided into two subscales:
negative affectivity and social inhibition [11]. A standard-
ised cut-off score of ≥10 on both subscales was used to
classify patients with Type D [11].
Anxiety symptoms were measured using the 7-item Gen-
eralised Anxiety Disorder (GAD-7) scale. Items on this
scale are rated on a 4-point Likert scale ranging from 0
(not at all) to 3 (almost daily) [12]. A cut-off value of ≥10
was used to identify patients with anxiety [12].
The 9-item Patient Health Questionnaire (PHQ-9) was
used to assess depressive symptoms. This questionnaire
scores each of the nine DSM-IV criteria for depression
on a 4-point Likert scale from 0 (not at all) to 3 (nearly
every day) [13]. A cut-off score of ≥10 was used to classify
patients with depression [13].
ICD concerns were measured using the 8-item ICD con-
cerns questionnaire (ICDC) [14, 15]. Items are scored on
a 5-point Likert scale from 0 (not at all) to 4 (very much
so). The scale yields a score for severity of concerns (0–32).
A higher score indicates more severe concerns [14, 15].
Loneliness was measured using the 10-item University
of California, Los Angeles Loneliness Scale (UCLA-R-S).
This scale consists of 20 items rated on a 4-point Likert
scale ranging from 1 (never) to 4 (very often). The higher
the patient’s score, the more loneliness he or she experi-
ences [16].
Statistical analyses
Baseline characteristics of compliant and noncompliant pa-
tients were compared using Fisher’s exact tests for discrete
variables and Mann-Whitney U tests for continuous vari-
ables. Frequencies with percentages (N (%)) are reported for
categorical variables and medians with interquartile ranges
(median (interquartile range—IQR)) for continuous vari-
ables. Multiple logistic regression analysis was used to
evaluate the association between patient characteristics and
compliance with driving restrictions. The level of statistical
significance was set at p < 0.05, and all analyses were per-
formed with SPSS 22.0 for Windows (SPSS Inc., Chicago,
Illinois).
Results
Patient characteristics and compliance rate
The sample (N = 313) had a median age of 64 (IQR =
55–71) years, and the majority was male (81%). Most pa-
tients received an ICD for primary prevention (69%). Me-
dian left ventricular ejection fraction was 29% (IQR =
23–35) and 47% of the patients were classified as hav-
ing mild heart failure symptoms (New York Heart Associa-
tion (NYHA) class II) at baseline. Prevalence of depression
and anxiety was 22 and 15%, respectively, and 14% of the
sample was classified as having a Type D personality. Me-
dian time between receiving the suitability statement from
their cardiologist and receiving the special driving license
was 2 weeks (IQR = 2–4). As shown in Tab. 1, 28% of
the patients reported to be noncompliant with the driving
restrictions within the first two months after implantation.
There were no significant differences in socio-demographic,
clinical and psychological factors between compliant and
noncompliant patients.
As shown in Tab. 2, almost all patients (97%) reported
they were informed about the driving restrictions, and gen-
erally they felt that information provision was sufficient
(81%) and delivered at the right moment (92%). Compli-
ant and noncompliant patients did not significantly differ
in their driving behaviour or opinions regarding informa-
tion provision. However, noncompliant patients were more
likely to have considered refusing the ICD because of driv-
ing restrictions than compliant patients (19% versus 10%,
p = 0.02). Also, noncompliant patients showed a tendency
towards being less likely to feel they understand the reason
behind the driving restrictions (75% versus 84%, p = 0.09).
Associated factors of compliance with the driving
restriction
The results of the multivariable logistic regression analy-
sis are shown in Tab. 3. Only the feeling of understanding
the reason behind the driving restrictions was associated
with compliance (odds ratio = 2.16, 95% CI 1.02–4.56, p =
0.04). This indicates that patients who feel they understand
the reason behind the restrictions were more likely to be
compliant. Socio-demographic, clinical, psychological and
other driving-related factors were not significantly associ-
ated with compliance.
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Table 1 Baseline characteristics of the total sample and stratified for compliance and noncompliance with driving restrictionsa
Total sample
N = 313
Compliance
N = 226 (72%)
Noncompliance
N = 88 (28%)
p-value
Socio demographic characteristics
Age 64 (55–71) 64 (54–71) 65 (59–70) 0.95
Female 59 (19%) 44 (20%) 15 (17%) 0.61
Having a partner 256 (82%) 186 (83%) 70 (80%) 0.42
Higher education (vocational or higher) 279 (91%) 198 (91%) 81 (92%) 0.35
Employed 112 (36%) 81 (37%) 31 (35%) 0.65
Smoking 33 (11%) 22 (10%) 11 (13%) 0.51
Use of alcohol 205 (66%) 147 (66%) 58 (66%) 0.96
Clinical characteristics
Body mass index 27 (24–30) 26 (24–30) 27 (25–29) 0.96
Left ventricular ejection fraction <35% 29 (23–35) 29 (24–35) 28.5 (22–37) 0.80
Ischaemic heart failure aetiology 135 (48%) 100 (49%) 35 (44%) 0.45
New York Heart Association class: 0.32
– Class I 91 (29%) 60 (27%) 31 (35%)
– Class II 146 (47%) 106 (48%) 40 (46%)
– Class III 68 (22%) 51 (23%) 17 (19%)
– Class IV 4 (1%) 4 (2%) 0 (0%)
Cardiac resynchronisation therapy 84 (27%) 62 (28%) 22 (26%) 0.73
Primary prophylactic indication 212 (69%) 154 (69%) 58 (67%) 0.78
Reports history of cardiac arrest 68 (22%) 48 (22%) 20 (23%) 0.91
Comorbiditiesb 153 (49%) 110 (49%) 40 (46%) 0.41
Psychological characteristics
Psychotropic medicationc 27 (9%) 21 (10%) 6 (7%) 0.44
Type D personalityd 42 (14%) 32 (15%) 10 (12%) 0.47
Anxietye 45 (15%) 31 (14%) 14 (17%) 0.59
Depressionf 69 (22%) 52 (23%) 17 (19%) 0.46
ICD concernsg 7 (2–13) 9 (3–14) 5 (2–11) 0.16
Lonelinessh 16 (12–22) 17 (12–22) 15.5 (12–22) 0.85
Categorical variables are reported as N (%) and continuous variables as median (interquartile range)
ICD implantable cardioverter defibrillator
aNoncompliance: driven a motor vehicle within the first 2 months after ICD implantation
bComorbidities are scored as present in case a patient reports to suffer from ≥1 of the following conditions: atrial fibrillation, diabetes mellitus
and chronic obstructive pulmonary disease
cUsing psychotropic medication is scored as present in case a patient reports to use ≥1 of the following categories: antidepressants, anxiolytics
and hypnotics
dType D personality: score of >10 on negative affectivity and social inhibition subscales of Type D scale (DS14)
eAnxiety: score of >10 on Generalised Anxiety Disorder (GAD-7) scale
fDepression: score of >10 on Patient Health Questionnaire (PHQ-9)
gICD concerns: total score ICD concerns questionnaire (ICDC)
hLoneliness: total score University of California, Los Angeles Loneliness Scale (UCLA-R-S)
Discussion
In our sample, 28% reported to be noncompliant with driv-
ing restrictions. Patients were able to apply for a special
driving license two months after implantation, and the ma-
jority received their license 2–4 weeks later. Previously,
three quantitative studies, two American and one Irish, ex-
amined compliance with physicians’ driving recommenda-
tions [7, 8, 17]. The prevalence of noncompliance varied
between 58 and 74% in American patients who were rec-
ommended not to drive during six months after implanta-
tion [7, 8]. Of the Irish patients who were advised to abstain
from driving for two months, 23% reported to be noncom-
pliant [17]. This indicates that shorter restrictions are asso-
ciated with better compliance. Yet, 28% noncompliance is
still a significant percentage, especially as this might be an
underestimation due to socially desirable answers regarding
compliance with driving restrictions [18].
Univariate analysis showed that noncompliant patients
more often considered refusing ICD treatment because of
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Table 2 Driving-related baseline characteristics of the total sample and stratified for compliance and noncompliance with driving restrictions
Total sample
N = 313
Compliance
N = 226
Noncompliance
N = 88
p-value
Owns driver’s license for:
– Vehicles 3,500 kg 304 (99%) 216 (99%) 88 (100%) 0.37
– Vehicles 3,500–7,500 kg 32 (11%) 22 (10%) 10 (11%) 0.74
– Vehicles to transport ≥8 persons 22 (7%) 15 (7%) 7 (8%) 0.74
Partner has driving license 211 (69%) 154 (70%) 57 (66%) 0.79
Main driver in family 237 (79%) 165 (77%) 72 (83%) 0.28
Driving >50% for work 114 (37%) 79 (36%) 35 (40%) 0.56
Driving >50% outside urbanised areas 267 (87%) 191 (88%) 76 (86%) 0.52
Number of kilometres per week 150 (79–300) 150 (73–300) 200 (95–350) 0.57
Informed about driving restriction 296 (96%) 214 (97%) 82 (94%) 0.20
Feels timing of information was good 276 (92%) 198 (91%) 78 (94%) 0.13
Feels information provision was sufficient 247 (81%) 179 (81%) 68 (78%) 0.45
Feels they understand reason 249 (81%) 185 (84%) 64 (75%) 0.09
Feels the restriction is too long 125 (42%) 95 (44%) 30 (35%) 0.13
Considered refusing ICD because of driving restriction 38 (13%) 21 (10%) 17 (19%) 0.02
Categorical variables are reported as N (%) and continuous variables as median (interquartile range), and significant results are presented in italic
ICD implantable cardioverter defibrillator
Table 3 Factors associated with compliance to driving restrictions
Compliance
OR 95% CI p-value
Female 0.81 0.36–1.80 0.60
Higher age 1.00 0.97–1.03 0.88
Having a partner 1.52 0.70–3.28 0.29
Higher education 1.18 0.64–2.20 0.60
Being the main driver 1.14 0.52–2.50 0.75
Having to drive to work 0.96 0.50–1.85 0.91
Feeling of understanding reason
behind restrictions
2.16 1.02–4.56 0.04
Accepting the driving restrictions 1.15 0.60–2.16 0.68
Higher body mass index 0.98 0.91–1.04 0.46
New York Heart Association class
≥II
1.49 0.71–3.13 0.29
Primary indication 0.94 0.48–1.84 0.85
Cardiac resynchronisation therapy 1.03 0.51–2.09 0.93
Comorbiditiesa 0.87 0.48–1.59 0.65
Type D Personalityb 1.63 0.64–4.16 0.31
Anxietyc 0.74 0.31–1.72 0.48
Depressiond 1.37 0.62–3.04 0.44
Considered refusing the ICD 0.60 0.26–1.40 0.24
Significant results are presented in italic
CI confidence interval, ICD implantable cardioverter defibrillator,
OR odds ratio
aComorbidities are scored as present in case a patient reports to
suffer from ≥1 of the following conditions: atrial fibrillation, diabetes
mellitus and chronic obstructive pulmonary disease
bType D personality: score of >10 on negative affectivity and social
inhibition subscales of Type D scale (DS14)
cAnxiety: score of >10 on Generalized Anxiety Disorder (GAD-7)
scale
dDepression: score of >10 on Patient Health Questionnaire (PHQ-9)
the driving restrictions, as well as a trend towards a limited
feeling of understanding the reason behind the restrictions.
In multivariate analysis, only the feeling of understanding
the reason was associated with better compliance and may
therefore be key in obeying the restrictions. This was con-
firmed in a Swedish qualitative study, where patients re-
ported that compliance depended on mutual understand-
ing and agreement between patients and physicians when
discussing the driving restrictions. Patients expressed that
noncompliance could occur if they felt their beliefs, ex-
pectations and preferences were not addressed or when the
information was unclear or delivered at an inappropriate
moment [5].
Contrary to previous American studies, we found no so-
cio-demographic, clinical, psychological or driving-related
factors that were significantly associated with compliance.
Craney et al. [7] found correlations between early resump-
tion of driving and the importance of maintaining one’s
lifestyle, driving for necessity or social reasons, and being
the main driver in the family. On the other hand, Hickey
et al. [8] found that noncompliant patients were more likely
to be younger, male, college educated, and to have ventricu-
lar tachycardia as index arrhythmia, compared to compliant
patients. This indicates that patient characteristics may have
less impact if the driving restrictions are shorter [7, 8].
After receiving a suitability statement from their cardiol-
ogist, Dutch patients can apply for a special driving license.
However, if they do not apply for a new driving license they
can keep their regular license without violating any laws.
In this case, patients may be held liable without any insur-
ance coverage if an accident occurs. Thus, it is important to
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note that driving is restricted, not prohibited by law. Many
patients find this confusing, which may complicate their
understanding of the driving restrictions [5]. To improve
compliance, it is important that patients feel they under-
stand the reason behind the restrictions, namely that the
risks associated with their heart disease (i. e. syncope due
to ventricular arrhythmia) can cause harm to themselves and
others while driving. When discussing the ICD implanta-
tion, physicians may simply ask their patients whether they
understand this underlying reason. If not, extra education
may positively influence the patient’s compliance. In ad-
dition, it would benefit patients’ understanding when Eu-
ropean recommendations regarding driving become more
uniform and standardised information on this topic is avail-
able for every country.
As the Dutch driving restrictions were published in 2000,
they were designed with secondary prevention ICD patients
in mind. Since MADIT II [19] and SCD-HeFT [20], how-
ever, the number of primary prevention ICD implantations
has vastly increased. Nowadays, the majority of the ICDs
is implanted for primary prevention (e. g., 69% in our sam-
ple). These patients are considered to have a lower risk of
sudden incapacitation than secondary prevention ICD pa-
tients [21], however, a distinction in driving restrictions is
currently lacking. This is confusing, as patients eligible for
primary ICD implantation are allowed to keep their normal
driving licenses without any restrictions if they decide to
refuse ICD implantation (provided they are not in NYHA
class III or IV). Although indication for ICD implantation
was not associated with compliance in this study, clini-
cal practice indicates that primary prevention ICD patients
often feel that the driving restrictions are unjust. In the
Netherlands, NYHA class III or IV patients are restricted
from driving due to severe heart failure symptoms. These
patients were not excluded from this study, as their NYHA
class could improve (e. g., after CRT-D implantation). We
performed a sensitivity analysis with NYHA I and II only,
as NYHA III and IV patients might already be used to
driving restrictions before ICD implantation. This sensitiv-
ity analysis yielded equal results, indicating that including
NYHA III and IV patients did not influence our findings.
Evidence supporting the driving restrictions is scarce,
which resulted in significant differences between countries,
European and non-European, regarding driving restrictions
after primary and secondary prevention ICD implantation
[2]. Over the past decade, driving restrictions have received
little attention in literature, even though patients experi-
ence these restrictions as bothersome. Better understanding
of patients’ incentives to comply with the driving restric-
tions after ICD implantation could enhance patient-centred
care. This study emphasised the importance to direct at-
tention towards the patient’s understanding of the reason
behind the restrictions. Additionally, uniform recommen-
dations, for example in Europe, and a distinction between
primary and secondary ICD patients might help enhance
patients’ acceptance and understanding of the driving re-
strictions.
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